Thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus

Acta Haematologica

Volumn 115, Issue 1-2, 2006, Pages 68-73

  Aleem, Aamer ^a   Al Sugair, Saleh ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Coombs test; Plasmapheresis; Systemic lupus erythematosus; Thrombotic thrombocytopenic purpura

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; COOMBS TEST; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; PLASMA TRANSFUSION; PLASMAPHERESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTIBIOTICS, ANTINEOPLASTIC; BLOOD COMPONENT TRANSFUSION; COOMBS' TEST; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PLASMA; PLASMAPHERESIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 31144459004     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089469     Document Type: Article

References (25)

1. Moschowitz E: Hyaline thrombosis of terminal arterioles and capillaries: a hitherto undescribed disease. Proc NY Pathol Soc 1924;24:21-24.
2. Amorosi EL, Ultmann JE: Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature. Medicine 1996;45:139-159.
3. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura: Canadian Apheresis Study group. N Engl J Med 1991;325:393-397.
4. Torok TJ, Holman RC, Chorba TL: Increasing mortality from thrombotic thrombocytopenic purpura in the United States - analysis of national mortality data, 1968-1991. Am J Hematol 1995;50:84-90.
5. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725 (letter).
6. Porta C, Caporali R, Montecucco C: Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects. Haematologjca 1999;84:260-269.
7. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrie PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B: von-Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-1584.
8. Tsai HM, Lian EC: Antibodies to von-Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585-1594.
9. Caramaschi P, Riccetti MM, Pasini AF, Savarin T, Biasi D, Todeschini G: Systemic lupus erythematosus and thrombotic thrombocytopenic purpura. Report of three cases and review of the literature. Lupus 1998;7:37-41.
10. Stricker RB, Davis JA, Gershow J, Yamamoto KS, Kiprov DD: Thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus. Case report and literature review from the plasmapheresis era. J Rheumatol 1992;19:1469-1473.
11. Porta C, Bobbio-Pallavicini E, Centurioni R, Caporali R, Montecucco CM: Thrombotic thrombocytopenic purpura in systemic lupus erythematosus. J Rheumatol 1993;20:1625-1626 (letter).
12. Musio F, Bohen EM, Yuan CM, Welch PG: Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum 1998;28:1-19.
13. Manadan AM, Harris C, Schwartz MM, Block JA: The frequency of thrombotic thrombocytopenic purpura in patients with systemic lupus erythematosus undergoing kidney biopsy. J Rheumatol 2003;30:1227-1230.
14. Devinski O, Petit C, Alonso D: Clinical and neuropathological findings in SLE: the role of vasculitis, heart emboli and TTP. Ann Neurol 1998;23:380-384.
15. Mannucci PM, Vanoli M, Forza I, Canciani MT, Scorza R: Von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis). Haematologica 2003;88:914-918.
16. Long Zheng X, Kaufman RM, Goodnough LT, Evan Sadler J: Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood; 103:4043-4049.
17. Matsuda J, Sanaka T, Gohchi K, Matsui K, Uchida J, Matsumoto M, Fujimura Y: Occurrence of thrombotic thrombocytopenic purpura in a systemic lupus erythematosus patient with antiphospholipid antibodies in association with a decreased activity of von Willebrand factor-cleaving protease. Lupus 2002;11:463-464 (letter).
18. Rick ME, Austin H, Leitman SF, Krizek DM, Aronson DL: Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS 13) and its inhibitor in a patient with thrombotic thrombocytopenic purpura. Am J Hematol 2004;75:96-100.
19. Moore JC, Hayward CPM, Warkentin TE, Kelton JG: Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders. Blood 2001;98:1842-1846.
20. Vesely SK, George JN, Lammle B, Studt J-D, Alberio L, El-Haraki MA, Raskob GE: ADAMTS13 activity in thrombotic thrombo-cytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in prospective cohort of 142 patients. Blood 2003;102:60-68.
21. Brunner HI, Freedman M, Silverman ED: Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood. Arthritis Rheum 1999;42:2346-2355.
22. Coppo P, Bengoufa D, Veyradier A, Wolf M, Bussel A, Millot GA, Malot S, Heshmati F, Mira JP, Boulanger E, Galicier L, Durey-Dragon MA, Fremeaux-Bacchi V, Ramakers M, Pruna A, Bordessoule D, Gouilleux V, Scrobohaci ML, Vernant JP, Moreau D, Azoulay E, Schlemmer B, Guillevin L, Lassoued K: Reseau d'Etude des Microangiopathies Thrombotiques de l'Adulte: Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count and mild renal involvement. Medicine (Baltimore) 2004;83:233-244.
23. Vasoo S, Thumboo J, Fong K-Y: Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: disease activity and the use of cytotoxic drugs. Lupus 2002;11:443-450.
24. Vaidya S, Abul-ezz S, Lipsmeyer E: Thrombotic thrombocytopenic purpura and systemic lupus erythematosus. Scand J Rheumatol 2001;30:308-310.
25. Allford SL, Hunt BJ, Rose P, Machin SJ, on behalf of the Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology: Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol 2003;120:556-573.